---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-22-000037"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2022-09-02T23:59:59+00:00"
generated_at: "2026-06-23T16:10:14.428966+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lexicon amends loan with Oxford Finance; $25M tranche drawable Dec 1-31, 2022

## Summary
- First Amendment to Loan and Security Agreement with Oxford Finance LLC executed Aug 29, 2022.
- Second $25M tranche draw period changed to Dec 1-31, 2022, subject to conditions and no Event of Default.
- Sotagliflozin NDA Milestone already achieved, as confirmed by Collateral Agent.
- Amendment fee and Lender Expenses payable; other loan terms unchanged.

## SEC filing metadata
- accession: 0001062822-22-000037
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2022-09-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282222000037/0001062822-22-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282222000037/lxrx-20220829.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-22-000037
- JSON: https://secwatch.observer/filing/0001062822-22-000037.json
- Plain text: https://secwatch.observer/filing/0001062822-22-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.